Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 3/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MME | P08473 | 1/20 | 0.31 |
| ▸ | ACE | P12821 | 1/20 | 0.31 |
| ▸ | CPA1 | P15085 | 1/20 | 0.31 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.31 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2133240 | 0.85 | TSHR (0.43) | TSHRSMN1; SMN2MMEACECPA1 | |
| SCHEMBL10580384 | 0.82 | ALDH1A1 (0.38) | TSHRSMN1; SMN2CYP3A4ATMTDP1 | |
| SCHEMBL2137937 | 0.79 | TSHR (0.40) | TSHRMAPTSMN1; SMN2MMEACE | |
| SCHEMBL1171002 | 0.77 | TSHR (0.34) | FAAHTSHRMAPTTDP1 | |
| Methane SCHEMBL28124547 | 0.77 | TSHR (0.39) | TSHRMAPTMMEACECPA1 | |
| SCHEMBL11879433 | 0.75 | CA2 (0.35) | FAAHTSHRMAPTSMN1; SMN2 | |
| SCHEMBL18338899 | 0.75 | TSHR (0.33) | FAAHTSHRMAPTSMN1; SMN2 | |
| SCHEMBL9420768 | 0.73 | MME (0.32) | SMN1; SMN2MMEACECPA1ACE2 | |
| SCHEMBL3087377 | 0.73 | CA1 (0.34) | TSHRCYP3A4ATMTDP1 | |
| SCHEMBL3081531 | 0.73 | ALDH1A1 (0.36) | TSHRMMEACECPA1ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8283095-B2 | Thiourethane compound and photosensitive resin composition | SHOWA DENKO K.K. (JP) | 2012-10-09 | — | — | US | disclosed |
| US-20100233596-A1 | THIOURETHANE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION | SHOWA DENKO K.K. (JP) | 2010-09-16 | — | — | US | disclosed |
| EP-2055726-A1 | THIOURETHANE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION | Showa Denko K.K. (JP) | 2009-05-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100233596-A1 | THIOURETHANE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION | RCOR3, CBR3, TAS2R3 | FAAH 3679/4885TSHR 3601/4885MAPT 712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.